BackAlterity Therapeutics Limited Overview

Alterity Therapeutics Limited Inventory

Latest inventory for PRNAF: $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

Alterity Therapeutics Limited Inventory History

Loading

Alterity Therapeutics Limited vs. peers: Inventory Comparison

Loading

Alterity Therapeutics Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alterity Therapeutics Limited (PRNAF) FAQ

Alterity Therapeutics Limited (PRNAF) currently reports a inventory of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Alterity Therapeutics Limited's inventory history and peer comparisons.

Alterity Therapeutics Limited's inventory changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterity Therapeutics Limited reported $0 in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alterity Therapeutics Limited, and consider following PRNAF for alerts when major investors trade the stock.

Alterity Therapeutics Limited is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRNAF with unrelated industries.